a start—up has beaten elon musk�*s neuralink company to fda—approved clinical trials in the race to implant a computer interface in a human brain. synchron announced its brain—computer interface the strentrode would undergo human trials in new york later this year. google is saying its us—based employees returning to work this autumn will need to be vaccinated. facebook quickly followed the search engine's lead, saying their employees would also need to be vaccinated to return to the office. and finally this week we saw for the first time and untethered, bipedal robot complete a five—kilometre run. the robot called cassie finished the journey in 53 minutes. cassie was designed by a team of researchers from oregon state university. it taught itself how to run on outdoor terrain using machine learning, and made it through on one battery charge. sadly i couldn't make it tojoin spencer in iceland — well, not in the traditional sense anyway. i am heading there in virtual reality though, for a spot of meditation. gentle piano music plays. it's a very serene theme, however much you look ar

available around the world and every country has its own regulator so here in the united states we have the fda. you look at the application and go from there. when we look at other countries they all have their own regulatory body goes to kind of process. it is unclear whether the drugmaker is going to apply in other countries to have this vaccine made available. it is good news for india because it we're looking at the population there anywhere from 9—13% are unvaccinated so a large amount of the population remains unvaccinated. is there an argument that we've got a handful of vaccines now and they are rolling out and we can concentrate our efforts and those rather than develop new ones? , . those rather than develop new ones? ,., . those rather than develop new ones? , . ., ., ones? there is an argument for that given _ ones? there is an argument for that given that _ ones? there is an argument for that given that we _ ones? there is an argument for that given that we have - ones? there is an argument for that given that we have a - that given that we have a number of safe and effective va

if you are a business leader, a nonprofit leader, a state local leader that is there waiting for fda approval i calling you now to do that, require it. in germany, tighter restrictions have come into force to access to a wide range of services such as hotels — swimming pools — hospitality and hairdressers. in most german regions access to these facilities in high infection areas will be restricted to those who have been vaccinated, tested negative or have recovered from the virus recently. the paralympics begin on tuesday and not only is para—badminton making its debut at tokyo 2020, so is india's rising star palak kohli. here's her story. my name is palak kohli and i'm an international pa ra—badminton athlete. i have transformed my disability into a super ability. even if the world says that it's not possible, but you have to say, "it's possible and i will show that." anybody who sees me for the very first time always asks me, "what has happened to your hand?" i used to say, "by birth." when i was a child, i didn't even know what the meaning of the word by birth, but i knew

you are a business leader, a nonprofit leader, state or local leader who has been waiting for full fda approval to require vaccinations, i call on you now to do that requirement. the paralympics are getting under way injapan and not only is para—badminton making its debut at tokyo 2020, so is india's rising star palak kohli. growing up disabled, palak never knew such a thing as the paralympics existed, let alone that she would go on to compete for her country. here's her story. my name is palak kohli and i'm an international pa ra—badminton athlete. i have transformed my disability into a super ability. even if the world says that it's not possible, but you have to say, "it's possible and i will show that." anybody who sees me for the very first time always asks me, "what has happened to your hand?" anybody who sees me for the very first time always asks me, "what has happened to your hand?" i used to say, "by birth." when i was a child, i didn't even know what the meaning of the word by birth, but i knew that i have to say this word. i never thought of taking any sports profession

the white house will hope the fda disicion encourages more to come forward. because right now the infection rate in headed in entirely the wrong direction. in florida dozens of doctors held a press conference this morning, describing the exhaustion and burn—out they're facing as the hospitalisations continue to surge. there's been a sharp uptick sincejuly — and as you can see, more than 15,000 people have been admitted in the 7 days to august 20th. dr rupesh dharia from palm beach internal medicine is one of those doctors and joins us now. he is one of those doctors who were involved this money. tell us why you felt it necessary to speak out today? felt it necessary to speak out toda ? ., ~ felt it necessary to speak out toda ? . ~' ,, felt it necessary to speak out toda ? ., .�* , felt it necessary to speak out toda? .,�* .�* , felt it necessary to speak out toda? .mg, ,�* , today? thank you. we've been, as we ointed today? thank you. we've been, as we pointed out — today? thank you. we've been, as we pointed out this _ today? thank you. we've

available around the world, as you know every country has its own regulator, here in the us we have the fda which, you look at the application and go from there. when we look at other countries they all have their own regulatory body that goes through a process, so it is a little unclear whether the drug maker is going to apply in other countries to have its vaccine made available. i think it is really good news for india because if we are looking at the population there, anywhere from 9— 13% are fully vaccinated, so there is a large population that still remains vulnerable. so we want to make sure they are protecting as many people as possible and it is good news for india. i5 is good news for india. is there an argument that we have a handful of vaccines rolling out now, we know they are working, let'sjust out now, we know they are working, let's just concentrate our efforts on those rather than developing new ones? there is an argument — than developing new ones? there is an argument that _ than developing new ones? there is an argument that even - than developing new ones? there is

available around the world and every country has its own regulator so here in the united states we have the fda enter you that the application go from there. with a good other countries in the all have their own regulatory body which goes through a process so it is a little unclear whether the drugmaker is going to apply in other countries to have the vaccine made available. it is good news for india because if we are looking at the population there anywhere from 9-13% population there anywhere from 9—13% are fully vaccinated so there is a large population that remains vulnerable so they want to make sure they are protecting as many people as possible and this is good news for india. i5 possible and this is good news for india. , ., ., for india. is there an argument that we know _ for india. is there an argument that we know we _ for india. is there an argument that we know we have - for india. is there an argumentj that we know we have vaccines so she would just concentrate efforts and rolling them out? there is an argument for that given we have a number of safe and effective vaccines arou

they are preferring to wait until the fda drug administration has approved the vaccination officially, but overwhelmingly, people who are not vaccinated have made a choice to not be vaccinated. some because they just have not got around to it and have procrastinated, but lots of others who either for reasons of faith, they are just choosing, that they will trust god, not to do with they will trust god, not to do with the vaccination, but more and more likely, it is those who have got bad information and rely on that bad information and rely on that bad information to put them on the fence, or has made them completely opposed to vaccination of this. soon i have this vaccine _ opposed to vaccination of this. soon i have this vaccine drive _ opposed to vaccination of this. soon i have this vaccine drive going, people taking it up? irate i have this vaccine drive going, people taking it up?— i have this vaccine drive going, people taking it up? we did it as a one-time event, _ people taking it up? we did it as a one-time event, yes, so - people taking it up? we did it as a one-time even

the fda approval is come through, i think that might mean that at the beginning of opening a conversation about vaccines being mandatory. but that domestic crisis certainly impacting the president. there's a movement right now in congress to consider the budget plan to consider the infrastructure. so many things in the heat of august that of course, pressing down on the president. at the front of his mind, rememberjoe biden has taken foreign policy very seriously. he's thinking about afghanistan since 9/11 in a very serious and deliberative way. this will be absolutely at the forefront of his mind and his efforts. doctor leshe of his mind and his efforts. doctor leslie vinjamuri, _ of his mind and his efforts. doctor leslie vinjamuri, thank— of his mind and his efforts. doctor leslie vinjamuri, thank you i of his mind and his efforts. doctor leslie vinjamuri, thank you very i leslie vinjamuri, thank you very much. a man who tricked the taliban to get his family on a british government plane out of kabul is now safely back in the uk. mohammad taher first arrived in this country as a refu

the fda has approved the pfizer vaccine, full approval. that means governments and corporations are starting to require, mandate vaccines for their employees. goldman sachs the latest to make that move. we are going to start on distrust with the health-care system. we want to talk what is going on with the hospitals and the burden they are under. of course, caroline, you brought this up earlier about some of the insurance issues. if those folks decide not to get vaccinated, what happens when they get covid and go to the hospital? does insurance cover it? caroline: that is a key question to ask. the point that they feel that will perhaps be the biggest wave , the vaccine mandates, and other things vaccines potentially bring to bear. it hasn't been the campaign to save your grandparents or the health risks for those around you. perhaps it might be the financial burden if you don't get vaccinated. taylor: some really cool charts that i know we are going to bring up here on if the fda approval moved the needle. a conversation we have been havi

pfizer biontech getting full fda approval. there has been a surge in infections, a big concern for investors. of course, all of these things will be front and center in jackson hole this week, which is also feeling the pain of the pandemic and the spread of delta. michael mckee is our policy correspondent. by the time we get to jackson hole, it will have a different feel than just a couple of weeks ago. mike: we thought the fed would be talking about when they might taper, but now it may be about whether they hold off because of what has happened with covid. cases in wyoming rising significantly. the county in which the symposium is held is going to code red. they say you cannot have meetings and everyone needs to be masked, you have to be social distanced. the kansas city fed decided to call it off, which is interesting. the fed had set us up for the idea that we may see a change in the operations. in their most recent meeting, they noted participants saw the path of the economy would depend on the course of the virus, risks

the fda approved the shots for 16 and older, while u.s. covid deaths topped 1000 for the first time since march. it is the first vaccine fully c urated. chinese companies seeking to go public in new york. some chinese firms received a detailed instructions about greater disclosure of their use of offshore vehicles for ipo's. they are reportedly being asked about the risk of chinese authorities might interfere with company operations. global news, 24 hours a day, on air and on quicktake by bloomberg, powered by more than 2700 journalists and analysts in over 120 countries. i am vonnie quinn. this is bloomberg. haidi? haidi: let's get to the markets and our next guest, jimmy chang, from new york. it was a nice day, that risk rally overnight. how much of the recovery prospects are being priced into markets as we continue to see the delta variance plague economies worldwide? jimmy: it is a back and forth story so far. the real test will come in september, post labor day, in the u.s., when the temporary unemployment benefit expires. we will see

we got the news that the fda did give pfizer full approval. most all sectors except for the safeties are in the green. 10 year yield now flat. interesting because we saw more selling earlier in the session, but now pretty much flat at 1.26%. bloomberg dollar index still down, but had a tremendous week last week, leading many to worry it was made -- it was maybe a bit overbought. crude up after seven sessions of losses, the worst week since february 2018. you can also imagine we are going to get a bounce. we were just really heavily sold when it came to the dollar. guy: absolutely, but you can see those all reversing. what comes next may comes down to what we see at later this week. the housing market clearly part of that narrative. we've got existing home sales data hitting the tape as we speak. 5.9 million, above expectations. the prime number has been revised higher. this is july data. we will talk to caliber homes a little later on. one of the factors in all of this is obviously that the fed is buying significant amounts of mortgages at the

what is the significance of this fda approval for booster shots? >> the people who are most likely to fall severely ill or die from coronavirus infection are those who don't have a strong immune system, who cannot work with the vaccine and th eir own a immunity to be the virus. the fda has said that group of people, people who have had an organ transplant or are fighting cancer, that they should get three doses of the vaccine. they are hoping it boosts their antibody levels so if they see the virus, they will have a better shot at beating it. this comes as other countries in the world don't have access to any vaccine at all. we are seeing an issue of any quality care across the world. when it comes to the u.s., where there is plenty of vaccine, they want to make sure it is getting to the people who need it most. >> that's the u.s.. and china, there are concerns about the efficacy of the vaccine in china but they have been successful in curbing the latest outbreak. what the have they been doing -- what have they been doing? >> china is doing everyth

that is something else i think that the fda will look at. shery: what we know about vaccine passports, and will there be a unified way that we can prove we are vaccinated? kara: no. i think there still remains a lot of political debate about that. here in the u.s. you have certain governors who have completely banned the idea of requiring proof of vaccination to go places. in the u.s. alone, it's a very tough sell. trying to enact globally would be even harder. haidi: san francisco bureau chief kara wetzel with the latest. meanwhile, qantas has demanded all of its staff be vaccinated or risk being fired. i will be speaking with the ceo in a few hours after their latest results at 2:15 p.m. here in sydney. vonnie: good morning. japanese prime minister yoshihide suga has expanded a state of emergency to cover more than 70% of the population. the delta variant surge lead to a record number of cases, and is straining the medical system. the curbs include the tokyo and osaka metro regions, and will now run until september 12. the move comes as ja

what i am watching is the fda. the expectation from the new york times is that the fda will grant full approval to the pfizer vaccine early next month. this may be something that triggers a greater pace of vaccinations. jonathan: we have been waiting for that. we are starting to see downgrades in china. that is worth focusing on, restrictions building in more than 40 cities. that really is worth paying attention to. tom: everybody anticipating the vice chairman's speech, i suggest it is about the weber economy. friday -- it is about the labor economy. friday is job reports. the bottom line is that there is a little bit of enthusiasm going into this report. jonathan: the adp report later this morning. jobless claims tomorrow. matt says the whisper number is something north of 500. your equities down on the s&p 500. 11754, yields unchanged -- 11754 , yields unchanged. lisa, muted price action going into payrolls this friday. lisa: good morning, this is wednesday. i feel like we should restart, you guys are whispering

that pfizer has full fda approval of its vaccine for covid. do you think we see higher vaccination rates in the u.s. because of this? emma: i certainly hope this will be the case. we have heard a lot of people of said they have had vaccine hesitancy because some of the vaccines do not have fda approval. i am hopeful this will get those people over that edge, making them feel comfortable enough they can get themselves vaccinated, which will make a difference with cases rising in summary places in the u.s. right now. guy: we need third shots? emma: this is a contentious point. so many people still have not had access to one shot, whereas most of the data we have shows after two shot you might not be fully protected forever against infections, your chances of hospital and death are still significantly lower. right now in a world where we do not have enough vaccine to go around we need to focus on getting the vaccines and the people that do not get vaccinated all, keeping the global transmission rate down and hoping to curb the rise of new variant

these things are getting held back because the fda has not approved it. they say it is probably going to happen this month. it needs to happen today. the quicker this happens, the better it is. we cannot allow bureaucracy to slow vaccine uptake and that is what is happening. lisa: you say it should be a priority to open schools in person. a lot of people agree with you. you said it was possible even in the prevaccine era. does that process include cutting down classes or sending people home who have contact with people who have covid, which can be disruptive? dr. adalja: definitely there is going to be disruption if you are in an area with high transmission. what we want to do in schools is designed them in such a way that the classroom does not lead to exposure. if you have a place in high humidity prevalence, you have to be careful about where you seat children, what types of activity they are participating in. the affections that occurred in schools in the prevaccine area were not due to sitting in a classroom. they were extracurricular activities, spo

as i handful doing it right after fda approval. many organizations already do it, sports, cruise ships. all of those types of things will move people to get vaccines. but if you want vaccinated people. kailey: if we do see people coming off the sidelines now that the shot has full approval, how quickly will that make a difference in terms of the case curve? dr. adalja: it takes a while to get fully vaccinated. if you're talking about pfizer, it is two doses two weeks apart. however, we know after people get the first doses in, about a week later, we start to see significant protection. if you got vaccinated yesterday or today, you might start seeing benefits in a week or two, but we have also seen vaccination rates go up even prior to the full fda approval. that may be something that also will have an impact. we are seeing some of the curves start to come down, but not quick enough. tom: thank you so much. a real stream of information. i put out on twitter that john murdoch's summary in the raging debate. lisa, this goes back to wh

the fda granted approval of the vaccine for ages 16 and up. so far, the shot has been allowed under emergency authorization. it is the first vaccine to be fully cleared by u.s. regulators. pres. biden: today i am calling on more companies in the private sector to step up the vaccine requirements that will reach millions more people. emily: joining us for more, emma court, who has been covering this. what does this mean for businesses? have we seen more businesses step fully authorized? emma: there -- businesses being empowered, we have already started seeing that come out of the government come out of other places. i think there is a real expectation that it will intensify even in the coming days. there has been some hesitation around this vaccine, these vaccines being emergency authorized, the idea being there is some gray area around whether you could require this for people. start getting cleared away with the approval today. emily: there also seems to be a great area around boosters. a lot of folks wondering, should i get it sooner? a lot

we had a headline out from the fda. so the cdc is joining with the fda and saying that the search might be necessary, it has been a pleasure, have a happy friday. i am matt miller. this is bloomberg. ♪ (announcer) back pain hurts, and it's frustrating. you can spend thousands on drugs, doctors, devices, and mattresses, and still not get relief. now there's aerotrainer by golo, the ergonomically correct exercise breakthrough that cradles your body so you can stretch and strengthen your core, relieve back pain, and tone your entire body. since i've been using the aerotrainer, my back pain is gone. when you're stretching your lower back on there, there is no better feeling. (announcer) do pelvic tilts for perfect abs and to strengthen your back. do planks for maximum core and total body conditioning. (woman) aerotrainer makes me want to work out. look at me, it works 100%. (announcer) think it'll break on you? think again! even a jeep can't burst it. give the aerotrainer a shot. pain and stress is the only thing you have

recently, the fda shifted their policy. they said showing an ultimate and if it of a slow-moving, difficult disease that we don't fully understand has been hard to prove drugs on. tom:tom: excuse me for interrupting. do you support that shift in fda policy? david: the regulator needs to make the decision about risk and benefit, but of course, we believe, lloyd reduction leads to slowing of the disease. we have been betting on that for some time, and put no yens behind it and research. now we have a leading pro duct in that area, which had the first trial in humans show positives. we said in q2, we are planning to submit this year under that new policy, and we think patients deserve access to that medication. but we are going to prove its worth just in the following year. we have a huge study going on that is almost enrolled, and will prove the benefit. lisa: the biogen drug was incredible controversial when it came out, and large part because of its price, in addition to the fda policy which did seem controversial within th

fda agreement to use the drug as well. now is the point in time where being a public company and able to access the capital that is needed to launch a drug like this is very important to us. amanda: do you feel as though we are in a new era for these kinds of drugs? we have seen a little bit more flexibility in the past two years, year-and-a-half will that benefit you? >> this is the first time that the fda emergency use authorization rules will emplace on a large-scale basis area the fda is still learning and the industry is still learning about how to use them. but, there is no question that rapidly being able to get drugs into the field and rescue patients at risk of thong from a public health emergency supersedes the slower efficacy process that has lived with us for so many years. kailey: thank you for your time and joining us. congratulations again on going public. a reminder for our audience, we are awaiting remarks from president biden after the passage of the 515 billion dollar bipartisan infrastructure plan. we w

the fda does not regulate it. they will not let you do it. insurance will not reimburse it. they need a good disease to do their thing. we have to change that mindset. how can flagship contribute to this, and we are doing this, we started five platform companies, whether it is creating new vaccines, all those things are trying to create an environment where governments and other corporations start to invest. david: today the average person's lifespan is in the mid 80's or something like that. do you think it is possible through things you might develop to live to 100, 110, 120? noubar: it is possible, i'm not sure it is a good thing. let alone on a planet that is daca -- dying. we have to think about our existence not only as individuals anymore than parasites in our liver think of whether we are going to live. if we don't start thinking about whether our planet is going to live, it is a moot point whether we as individuals live to 110. there is a reckoning, we have to create an environment in which it is worth living. david: did your parents live to see your success? noubar

now that we have full fda approval, we can use the same safe policies we had with influenza. if i work at johns hopkins hospital, i have to have proof of vaccination and that complete makes sense. >> does the full fda approval change anything on the margins against those who may have been hesitant? dr. hansoti:. completely. there is an estimation -- dr. hansoti: completely. there is an estimation that about -- full fda approval, we can rest assured and reassure those individuals that this is the same as any other vaccine. this isn't something new, something it is risky. this has the same data and the same level of approval as all the other treatments that they would take normally. >> what work is being done to get children vaccinated? tom brings up polio and likens us back a couple decades or so. what are the efforts on that front. dr. hansoti: the clinical trials, the data is being combed through. we are expecting eua approval any day now. pediatricians already have infrastructure to be able to vaccinate children quickly and effectively. i think it is going to be very simple

i think the closer we get to some form of waving the wand by the fda, maybe things change. lisa: in the meantime i wonder how much this weighs on sentiment at a time people feel less confident going out to eat, less confident flying on a plane. canceling vacations. people are concerns about flying to get. tom: i cancel all of my vacations. lisa: [laughter] is that so. tom: futures date of 19. the tape approves fractionally. dow futures -171. stay with us through the day on bloomberg radio and bloomberg television. ♪ >> i have an exclusive western and southern update for bloomberg tv from tennis channel. one of the biggest tops in the pro tour got underway in cincinnati. two time wimbledon champion got up to the perfect start after she took out american medicine keene. after edging the opening 7-5 the stock -- the start needed a single break in the second after an hour and a half. the reigning french open champion also moving on. the world number 10 looking very impressive as she dispatches -- and also got off to a good start. the three-time winners had to work hard. the s

what does the pfizer shot mean toward getting more acceptance of the vaccine with the fda approving it? >> we are seeing vaccinations become much more part of the natural landscape. getting your annual shots, getting her childhood shot, that is something everybody goes through. that is something we do for measles, mumps, rubella, it is why we don't have polio. that is where we are moving to with these covid-19 shots. when they first came out, it was unbelievably fast, the development of the shots and they got an emergency use authorization. it was an emergency. we did not have all the data we wanted. now that we are almost two years into the pandemic, we have better data and the cdc and the fda is saying, now we can actually look at the evidence we have and determine whether we think this is going to be a fundamental piece of our landscape going forward. the fda has approved the pfizer shot and now the cdc makes the recommendation of whether this is something that should just be part of the standard script for everybody. it certainly looks like that is what they are going to do and per

ndma and the fda will follow. so i think that this is just the first step of a cascading number of regulatory filings. emily: let's focus on places you have submitted filings. when do you believe the vaccine will be available and where? stan: what is going to be available is we are stockpiling vaccine now and stockpiling tens of millions of doses so that when the regulatory agencies do approve, we are able to ship at a moments notice. almost -- the sequence of approvals will come presumably from one of the three -- one or more of the three agencies we filed with. we are not in the business of predicting how quickly the regulatory agencies will approve but i can give you insight that, although we have just submitted the data, within the last days, we have had meetings with a substantial number of people in these agencies going over all of the questions you would expect to be asked. they have begun the intense review process. i can't predict when it is going to be reviewed, or when it is going to be approved, but th

taylor: does the full fda approval on monday and the upcoming expectations of the next fda approval of the next vaccine, does that change the game on the margin? dr. pekosz: i do hope so. the data that led to the full approval of the pfizer vaccine and data that will lead to the full approval of the moderna vaccine has been out there for months. we have seen it, it is fantastically good data in terms of safety and efficacy, and this full approval i hope will drive not only more people to reconsider their decision not to be vaccinated and go forward with it, but at the end of the day, it may validate mandates for certain types of work, certain types of activity because we have the data, it is clear the vaccines are safe and are working, we need to use them more efficiently and more effectively to get the pandemic under control. tom: thank you so much dr. pekosz. the idea here at jackson hole, there will be the speech of the bankers, the chairman, all of that and then a lunchtime speech under the beautiful tents. in the papers, the kansas city fed's tradition is to keep the papers under

careful line to to end it does stem the ideological divide and a lot of people are waiting for the fda to come up with full approval for the vaccines and then he will start getting mandates. tom: it will be a twisted august. none of us have any vacation days left. will be here all through august. stay with us. the economic advisers. dr. fuhrman. this is bloomberg on radio, on television. ♪ (announcer) looking for a better way to lose weight and feel good? how about the one with the 98% success rate and the more affordable weight loss solution? that's golo. there are no monthly fees and it's guaranteed to work or you don't pay. how can golo offer all of that? because it's not like any of those diets you've already tried. it's the new way to lose weight. no stimulants, no starving, just results. results you'll keep for life. no more sacrificing to lose weight only to put it back on. no more sacrificing, period. it improves your lifestyle and delivers incredible results. with over 2 million satisfied customers, golo is the new way to lose weight. this is the only program i have ever don

the companies already announced they started an application with the fda for a third dose. reiser and biontech say they plan to complete submission by the end of the week, bringing them one step closer to clearance. yoshihide suga has expanded the state of emergency to cover more than 70% of the population. the delta variant surge has led to a record number of cases and is straining the medical system. the curbs include the tokyo and osaka metro regions which will run until september 12. the move comes as japan hosts the paralympics and as suga's support drops to record lows. bloomberg has learned the latest soon to be released u.s. intelligence report on the origins of covid-19 is inconclusive as beijing warns a retaliation against those questioning whether the virus leaked from its labs. china's foreign director general made the comments ahead of the report's release. he says while beijing will cooperate with groups like the who, detractors should be prepared to accept the counter attack. the w.h.o.'s backing a proposal to set up a $10 billion and to plug the financial ga

we will see if that is the case or whether the fda will need additional data from them too. emily: all right. thank you so much for your analysis and the updates. we appreciate it. ok. coming up, all eyes on texas, as a startup looks at the longhorn state to build one of their newest car factories. we will have the latest next. plus, later, we will speak with reid hoffman, joby going public, the more about urban and aerial transport ahead. this is bloomberg. ♪ comcast nbcuniversal is investing in entrepreneurs to bring what's next for sports technology to athletes, teams, and fans. that's why we created the sportstech accelerator, to invest in and develop the next generation of technology that will change the way we experience sports. we've already invested in entrepreneurs like ane swim, who develops products that provide hair protection so that everyone can enjoy the freedom of swimming. like the athletes competing in tokyo, these entrepreneurs have a fierce work ethic and drive to achieve - to change the game and inspire the team of tomorrow. emily: welcome back to "blo

michelle, we are seeing potentially a september approval for the pfizer vaccine for the fda. where are we at in terms of full approval elsewhere and will that help? michelle: it is possible full approvals will help hesitancy. there are people who are saying these vaccines are still experimental because they have not been fully approved and that is one of the talking points when it comes to vaccine hesitancy and the anti-vaccination groups. to be honest, people have really heard plenty of information at this point about the vaccine. what we will need to do is make it very easy for people to get access to the vaccine if they are just nervous about it or having difficulty getting it. in many places in asia, they haven't been able to get it. we heard the ceo of novavax saying they are ramping up to start rolling it out here. counterintuitively, some outbreaks will be the things that encourage people to get vaccinated. in sydney, five people died in the past couple of days. four were unvaccinated. when you start seeing people dying because they didn't get vaccinated, that moves th

more broadly, what is the response given the fda approval for the pfizer shot? reporter: the fda approval is expected to pave the way for more vaccine mandates as employers feel more comfortable, composing this on their employees. the idea that having full approval will make people who were on the fence do so. goldman sachs comes in today, they have had workers back for two months, the more aggressive companies in bringing back workers. they are taking a big step of requiring vaccines since the announcement. you also have cvs say clinical and corporate workers have to get vaccines. chevron requiring some workers in the gulf of mexico. starting to see more vaccines come into play, and i think in the coming days, you will see more companies jumping. haidi: at the same time, we are seeing the waning effectiveness against the delta variant. kara: there is a cdc report that showed a survey of front-line workers, that the vaccines are 65% effective against the delta variant. some concerns there about the diminished effectiveness. the cdc is expected to use this data f

the fda granted approval for the short for people 16 and older, as u.s. average covid daily deaths topped 1000 for the first time since march. it is the first vaccine to be fully cleared by u.s. regulators. this company has started issuing new disclosure requirements as the chinese company is seeking to go public in new york. they are also reportedly being asked about the risks of the chinese authorities may interfere with company operations. the taliban say there will be consequences if the u.s. delays its troop withdrawal from afghanistan past the august 30 one deadline. u.k. prime minister borris johnson is said to be pushing president biden to delay the pullout. the airlift is expected to dominate discussions. the pentagon says military officials are in constant contact with the taliban, coordinating evacuation efforts. prime minister justin trudeau has expanded out of the block in the campaign. his prospects for a majority or weakening. preliminary surveys still give his party the advantage but it has dwindled. canadians vote on september 20. ships h

the fda has cleared these vaccines. companies now are respecting them to start mandating the vaccines. requiring them to get it. when we talk about the delta variant itself, there's a study that came out that shows that what we've been concerned about is happening. the protectiveness of the vaccine does wane over time, especially as the delta variant started emerging. the study looked from the end of december through this month and it showed that the mrna vaccines are about 66% effective at preventing infection. that is significantly less effective than it was originally against the wild type that we first saw when it was 91% effective. it's important to keep these numbers in perspective. 66% is still pretty good, at the top of the range that we were hoping for before we knew how good the mrna vaccines were going to be. it's doing a better job at preventing serious infections, hospitalizations, and deaths. the idea that you can pass around the virus even if you are vaccinated is why you have to wear your mask. tom: inde

we heard from an fda official this week who said they might come out with a strategy in the next two months. that is a separate comment from that which we are seeing from pfizer and bitter, both of which have been advocating for boosters. the dharna just today -- moderna suggesting we should get going and boosting. there was good news tucked into the earnings report, efficacy at the six-month mark only waned by one percentage point from 94% to 93%. we can remain comfortable, but the first that are going to get that boost are most likely going to be older americans and the immunocompromised. dave: of coursedave: -- emily: there are children that still can't get vaccinated. delta is surging as kids go back to school. in california, we find out teachers do not have vaccine mandates. when will a vaccine be available for children under 12? riley: for children 12 and under, we are waiting on data that is being collected in real time right now. pfizer expects data for the under 12 population could come as soon september. add that to dr. fauci's comments who say we should see all children el

>> what we are hearing is that the fda is close to approving that third booster shot. we are talking about people who are on medication to suppress the immune response. their immune systems need a very strong dose of that vaccine to elicit that antibody response. we know that from the trials we have seen, half of those patients have a significant vaccine response once they get a third shot. it is a small and special group but definitely the fda is paving the way to start rolling out these third rounds of shots, these booster shots, partly because of that fear of delta just sweeping through the country. dani: we have seen various entities, the pentagon or individual companies, from employees coming back to the office, mandate vaccination. where do we stand on this trend? are these just one offs we are seeing, mandated vaccinations? rachel: we are seeing this become more and more common across the u.s. people forget the u.s. had a strong start with vaccinations but plateaued at a low level, just below 50%. in contrast, europe, germany, the u.k., getting into the 60's and

matt: why doesn't the fda fully approve the covid-19 vaccines out there? so many are hesitant to take vaccine, a lot of them are concerned because of this information have seen on social media, but others may be looking at the fda and saying, i'm not going to take it until they approve it. patrick: the issue when it comes to beck's analogy is long-term immunity. i cannot speak to the decision-making process, but i believe everyone should get the vaccine. it definitely reduces death risk. but we need to go now to what i call the second-generation vaccines. immunitybio is taking the approach that we will become the universal boost. long-term we need to figure out a rna and dna combination. rna looks to give you the best antibodies and dna can give you t cells. right now, we are taking our dna vaccine and making that the third booster, so to speak, of both the johnson and johnson and pfizer vaccine in south africa. greg: to get people on board with this, is there a mind shift needed? for a while we were hopeful that this first round of vaccines were the answe

he says he asked the fda to get generic drugs to people faster. we will continue to follow this for you and bring you any headlines. you can also watch the speech on the bloomberg terminal. live go is the best place to follow. electric volvo trucks are hitting the streets of new york city for the first time. we will speak to volvo trucks north america president peter voorhoeve. this is bloomberg. ♪ matt: this is bloomberg markets. i'm matt miller with amanda lang. volvo's electric trucks are hitting the streets of new york city for the first time, being deployed as a part of manhattan beer distributors's fleet of trucks serving 25,000 first to customers. peter voorhoeve joins us now to discuss. i have always said, if this doesn't work out for me, i would like to be a truck driver or beer distributor. i guess i would have the chance to do both here. aside from that, thanks for joining us. what will we see with this experiment? it is a pretty large fleet. peter: thank you for having me. very excited to be on your show. this is a big day for us, fo

we will see if that is the case or whether the fda will need additional data from them too. it is still too early to tell. emily: all right. thank you so much for your analysis and the updates. we appreciate it. ok. coming up, all eyes on texas, as in amazon-backed startup looks at the longhorn state to build one of their newest car factories. we will have the latest next. plus, later in the show, we will be speaking with reid hoffman, who just took joby aviation public. we will have more on the future of urban and aerial transport ahead. this is bloomberg. ♪ in business, it's never just another day. it's the big sale, or the big presentation. the day where everything goes right. or the one where nothing does. with comcast business you get the network that can deliver gig speeds to the most businesses and advanced cybersecurity to protect every device on it— all backed by a dedicated team, 24/7. every day in business is a big day. we'll keep you ready for what's next. comcast business powering possibilities. emily: welcome back to "bloomberg technology." i am emily chang